ImmunityBio, Inc. IBRX
At closeNov 12, 2026, 4:00 PM EST
After hours · Nov 12, 4:00 PM ET
- YTD
- +206.57%
- 1 year
- +194.66%
Discussion (3506)
Sign in to join the discussion
I am up 3 million
I laugh every day price needs to do XYZ needs to hold X I LMAO daily at the wasted energy and stupidity.
Where will the price be 6mo 1 2 3 5 10
Years not what it will be today tomorrow and in week.
I am 68 retires at 52 and I invest I invested 2.5 million in IBRX 520,000 share never sold a single share
"Keytruda’s rapid, broad approval for over 20 cancers stems from its unique mechanism as a PD-1 inhibitor that unleashes the immune system across many tumor types, combined with FDA accelerated approvals, Breakthrough Therapy designations, and large-scale, adaptive clinical trials (KEYNOTE studies). It was often approved based on early, dramatic phase 1 data"
So why hasn't Anktiva been granted the same???????
Big Pharma
MSM
FDA ,corruption
If and we should get Keytruda size approvals stock goes triple digits
Paul Silberberg is the most. Knowledgeable person to post on this board
Larry OMG Trump is busy we are at war
Send to RFK Jr Makary Bhattacharya
GM from Scottsdale Az and back to sleep for me :) it's 2:40am
